SUCCESS: Series of Unique Creative Continuing Education Self Studies

You are not logged in. (Login)


CEU COURSES | TRANSFUSION THERAPY teh

Indications for Transfusion (Release Date: 06/14/2017) I ndications are established reasons for transfusion, which will benefit the patient. However blood components are drugs and can have adverse effects and should not be administered indiscriminately. This course will highlight the main indications and some of the adverse effects that can occur with the transfusion of red blood cells, plasma, and platelets.

Group AB Plasma and the Risk of TRALI (Release Date: 2/20/2012)
This presentation begins with two case reports of fatal TRALI, followed by a discussion of TRALI diagnosis and pathogenesis. The role of group AB plasma in these reactions is outlined and recommendations that hospitals restrict group AB plasma use to those patients who absolutely require it are explained in detail.

American Rare Donor Program (Release Date: 10/01/2009)
The role of the American Rare Donor Program in assisting in the transfusion management of patients requiring rare or IgA-deficient blood products is presented. Discussions also include the use of the monocyte monolayer assay and transfusion of incompatible blood.
Transfusion Management of the IgA-Deficient Patient (Release Date: 10/01/2009)
The laboratory evaluation and transfusion management of IgA-deficient individuals, who may or may not have a history of prior anaphylaxis, is reviewed. American Rare Donor Program blood product release criteria and blood product selection are also discussed.

What's New with Granulocyte Transfusions (Release Date: 07/01/2009)
Issues related to granulocyte transfusions are reviewed, including indications for transfusion, ordering products and administration. Product-related issues including regulations, product dose and donor safety are covered. Future research efforts are highlighted. NOTE: when you review the lecture on granulocytes, you will see references to the RING Study. This study was designed to test the efficacy of high doses of granulocytes and antimicrobial therapy compared to antimicrobial therapy alone in neutropenic patients. The study failed to accrue the targeted number of patients and closed in 2014. There was no difference between the two groups, but because of the low accrual, the study was under-powered.

Adverse Reactions to Transfusion (Release Date: 09/10/2014) Some adverse reactions are preventable but many cannot currently be anticipated or avoided. Prompt recognition of suspected reactions and cessation of transfusion limit their severity and can prevent fatalities. This course provides an overview of adverse transfusion reactions and reviews steps to prevent them or limit their severity.

Clinical Case conference: Autoimmune hemolytic anemia (Release Date: 04/10/2015) Anemia can result from different causes and and correctly diagnosing its source can be challenging. Transfusion therapies that will result in successful clinical management of anemia require correct laboratory diagnosis. Prompt recognition of suspected reactions and cessation of transfusion limit their severity and can prevent fatalities. This course provides an overview of adverse transfusion reactions and reviews steps to prevent them or limit their severity.

Septic Transfusion Reactions: Lessons from the Headlines and Hemovigilance (Release date: 12/07/2015) Septic reactions from apheresis platelet transfusion are a leading cause of morbidity and mortality, but there are opportunities to increase awareness, recognition and reporting that could improve safety for patients.

Practical Coagulation for the Blood Bank (Release date: 06/30/2016) This course provides a summary of the general coagulation model which includes initiation, amplification and propagation. There is also a look at thrombin’s role in clot formation as well as a review of the common coagulation tests and the major drugs used in coagulation abnormalities.

An Introduction to Pathogen Reduction (Release date: 08/31/2016) This course defines the concept of pathogen reduction, describes the pathogen reduction systems available for blood components and summarizes the studies conducted to date.